Potentiometric Acetylcholine Biosensor Based on Molybdenum Trioxide Film-Modified Tungsten Trioxide Nanoparticles and Dual-Enzyme

被引:0
作者
Chou, Jung-Chuan [1 ]
Chen, Yu-Wei [1 ]
Lai, Chih-Hsien [1 ]
Yang, Po-Hui [1 ]
Kuo, Po-Yu [1 ]
Nien, Yu-Hsun [2 ]
Chen, Wei-Shun [1 ]
Huang, Jyun-Ming [1 ]
机构
[1] Natl Yunlin Univ Sci & Technol, Grad Sch Elect Engn, Touliu 64002, Yunlin, Taiwan
[2] Natl Yunlin Univ Sci & Technol, Grad Sch Chem & Mat Engn, Touliu 64002, Yunlin, Taiwan
关键词
Acetylcholine biosensor; molybdenum trioxide (MoO3); tungsten trioxide nanoparticles (WO3 NPs); ACID;
D O I
10.1109/JSEN.2024.3459417
中图分类号
TM [电工技术]; TN [电子技术、通信技术];
学科分类号
0808 ; 0809 ;
摘要
In this study, we introduce a novel potentiometric biosensor for acetylcholine detection that integrates molybdenum oxide, tungsten trioxide nanoparticles, and dual enzymes: acetylcholinesterase and choline oxidase. This biosensor represents a new application of metal oxides in acetylcholine detection, showcasing the hydrothermal synthesis of tungsten trioxide nanoparticles. Their successful synthesis was confirmed via X-ray diffraction. The molybdenum trioxide (MoO3) film was deposited on a flexible printed circuit board (FPCB) through radio frequency sputtering and further modified with tungsten trioxide nanoparticles, acetylcholinesterase, and choline oxidase to significantly enhance the biosensor's performance, exhibiting high sensitivity, rapid response, high selectivity, and low detection limit. The surface and thickness were characterized by field emission scanning electron microscopy. Experimental results demonstrate that the modified acetylcholine biosensor exhibits an exceptional sensitivity of 60.79 mV/decade across a concentration range of 0.01-100 mu M.
引用
收藏
页码:33953 / 33961
页数:9
相关论文
共 44 条
  • [1] Huang Q., Liao C., Ge F., Ao J., Liu T., Acetylcholine bidirectionally regulates learning and memory, J. Neurorestoratol., 10, 2, (2022)
  • [2] Inayat S., Et al., Low acetylcholine during early sleep is important for motor memory consolidation, Sleep, 43, 6, (2019)
  • [3] Myslivecek J., Two players in the field: Hierarchical model of interaction between the dopamine and acetylcholine signaling systems in the striatum, Biomedicines, 9, 1, (2021)
  • [4] Fang C., Lv L., Mao S., Dong H., Liu B., Cognition deficits in Parkinson's disease: Mechanisms and treatment, Parkinson's Disease, 2020, pp. 1-11, (2020)
  • [5] Chen Z.R., Huang J.B., Yang S.L., Hong F.F., Role of cholinergic signaling in Alzheimer's disease, Molecules, 27, 6, (2022)
  • [6] Marucci G., Buccioni M., Ben D.D., Lambertucci C., Volpini R., Amenta F., Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease, Neuropharmacology, 190, (2021)
  • [7] Mane-Damas M., Et al., Novel treatment strategies for acetylcholine receptor antibody-positive myasthenia gravis and related disorders, Autoimmunity Rev., 21, 7, (2022)
  • [8] Kojima Y., Et al., Rate of change in acetylcholine receptor antibody levels predicts myasthenia gravis outcome, J. Neurol., Neurosurg. Psychiatry, 92, 9, pp. 963-968, (2021)
  • [9] Ganie S.Y., Javaid D., Hajam Y.A., Reshi M.S., Mechanisms and treatment strategies of organophosphate pesticide induced neurotoxicity in humans: A critical appraisal, Toxicology, 472, (2022)
  • [10] Zeng S., Et al., Role of hemoperfusion combined with hemodialysis in acute severe organophosphorus pesticide poisoning: A meta-analysis, Emergency Crit. Care Med., 3, 4, pp. 177-193, (2023)